Related Experiment Video
Updated: May 10, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Exploring Acute Pancreatitis After Orlistat Use: A Case Report
Abeer Qasim1, Abhilasha Jyala1, Ornela Thartori1
1Internal Medicine, BronxCare Health System, Bronx, USA.
Orlistat, a lipase inhibitor for obesity, may be linked to acute pancreatitis. This case study and literature review explore this potential adverse event in patients using this common medication.
Area of Science:
- Pharmacology
- Gastroenterology
- Clinical Case Studies
Background:
- Orlistat is an FDA-approved pancreatic lipase inhibitor for obesity management.
- It is widely available over-the-counter in many countries, leading to increased usage.
- Rising utilization necessitates a comprehensive understanding of potential adverse events.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment: